Washington University in St. Louis (WU)
Dr. Fehniger is interested in understanding innate immunity and its relationship to cancer. He focuses on the molecular and cellular biology of one innate immune lymphocyte, the natural killer cell, and developing translational immunotherapy strategies that utilize natural killer cells to fight cancer.